Identification of heat shock protein 32 (Hsp32) as a novel survival factor and therapeutic target in neoplastic mast cells - PubMed (original) (raw)
. 2007 Jul 15;110(2):661-9.
doi: 10.1182/blood-2006-10-054411. Epub 2007 Apr 9.
Karoline V Gleixner, Matthias Mayerhofer, Anja Vales, Alexander Gruze, Puchit Samorapoompichit, Khaled Greish, Maria-Theresa Krauth, Karl J Aichberger, Winfried F Pickl, Harald Esterbauer, Christian Sillaber, Hiroshi Maeda, Peter Valent
Affiliations
- PMID: 17420286
- DOI: 10.1182/blood-2006-10-054411
Free article
Identification of heat shock protein 32 (Hsp32) as a novel survival factor and therapeutic target in neoplastic mast cells
Rudin Kondo et al. Blood. 2007.
Free article
Abstract
Systemic mastocytosis (SM) is a myeloid neoplasm characterized by increased survival and accumulation of neoplastic mast cells (MCs). In most patients, the D816V-mutated variant of KIT is detectable. We report here that heat shock protein 32 (Hsp32), also known as heme oxygenase-1 (HO-1), is a novel KIT-inducible survival factor in neoplastic MCs. As assessed by reverse transcription-polymerase chain reaction (RT-PCR), immunocytochemistry, and Western blotting, the KIT D816V(+) MC line HMC-1.2 as well as highly enriched primary neoplastic MCs were found to express Hsp32 mRNA and the Hsp32 protein. Moreover, KIT D816V and stem cell factor (SCF)-activated wild-type KIT were found to induce Hsp32 promoter activity, expression of Hsp32 mRNA, and expression of the Hsp32 protein in Ba/F3 cells. Correspondingly, the KIT D816V-targeting drug PKC412 decreased the expression of Hsp32 as well as proliferation/survival in neoplastic MCs. The inhibitory effects of PKC412 on the survival of HMC-1.2 cells were counteracted by the HO-1 inductor hemin or lentiviral-transduced HO-1. Moreover, 2 Hsp32-targeting drugs, pegylated zinc protoporphyrin (PEG-ZnPP) and styrene maleic acid copolymer micelle-encapsulated ZnPP (SMA-ZnPP), were found to inhibit proliferation and to induce apoptosis in neoplastic MCs. Furthermore, both drugs were found to cooperate with PKC412 in producing growth inhibition. Together, these data show that Hsp32 is an important survival factor and interesting new therapeutic target in neoplastic MCs.
Similar articles
- Identification of heat shock protein 32 (Hsp32) as a novel target in acute lymphoblastic leukemia.
Cerny-Reiterer S, Meyer RA, Herrmann H, Peter B, Gleixner KV, Stefanzl G, Hadzijusufovic E, Pickl WF, Sperr WR, Melo JV, Maeda H, Jäger U, Valent P. Cerny-Reiterer S, et al. Oncotarget. 2014 Mar 15;5(5):1198-211. doi: 10.18632/oncotarget.1805. Oncotarget. 2014. PMID: 24681707 Free PMC article. - Targeting of heat-shock protein 32/heme oxygenase-1 in canine mastocytoma cells is associated with reduced growth and induction of apoptosis.
Hadzijusufovic E, Rebuzzi L, Gleixner KV, Ferenc V, Peter B, Kondo R, Gruze A, Kneidinger M, Krauth MT, Mayerhofer M, Samorapoompichit P, Greish K, Iyer AK, Pickl WF, Maeda H, Willmann M, Valent P. Hadzijusufovic E, et al. Exp Hematol. 2008 Nov;36(11):1461-70. doi: 10.1016/j.exphem.2008.06.002. Epub 2008 Aug 23. Exp Hematol. 2008. PMID: 18723263 - Identification of MCL1 as a novel target in neoplastic mast cells in systemic mastocytosis: inhibition of mast cell survival by MCL1 antisense oligonucleotides and synergism with PKC412.
Aichberger KJ, Mayerhofer M, Gleixner KV, Krauth MT, Gruze A, Pickl WF, Wacheck V, Selzer E, Müllauer L, Agis H, Sillaber C, Valent P. Aichberger KJ, et al. Blood. 2007 Apr 1;109(7):3031-41. doi: 10.1182/blood-2006-07-032714. Blood. 2007. PMID: 17110460 - Targeting the KIT activating switch control pocket: a novel mechanism to inhibit neoplastic mast cell proliferation and mast cell activation.
Bai Y, Bandara G, Ching Chan E, Maric I, Simakova O, Bandara SN, Lu WP, Wise SC, Flynn DL, Metcalfe DD, Gilfillan AM, Wilson TM. Bai Y, et al. Leukemia. 2013 Feb;27(2):278-85. doi: 10.1038/leu.2012.218. Epub 2012 Jul 31. Leukemia. 2013. PMID: 22907049 Free PMC article. Review. - Heme oxygenase 1: a novel oncogene in multiple gynecological cancers.
Lu JJ, Abudukeyoumu A, Zhang X, Liu LB, Li MQ, Xie F. Lu JJ, et al. Int J Biol Sci. 2021 Jun 1;17(9):2252-2261. doi: 10.7150/ijbs.61073. eCollection 2021. Int J Biol Sci. 2021. PMID: 34239353 Free PMC article. Review.
Cited by
- Advancements in Genetic Biomarkers and Exogenous Antioxidant Supplementation for Safeguarding Mammalian Cells against Heat-Induced Oxidative Stress and Apoptosis.
Khan MZ, Khan A, Chen W, Chai W, Wang C. Khan MZ, et al. Antioxidants (Basel). 2024 Feb 20;13(3):258. doi: 10.3390/antiox13030258. Antioxidants (Basel). 2024. PMID: 38539792 Free PMC article. Review. - On the Question of CO's Ability to Induce HO-1 Expression in Cell Culture: A Comparative Study Using Different CO Sources.
Yang X, Mao Q, Wang B. Yang X, et al. ACS Chem Biol. 2024 Mar 15;19(3):725-735. doi: 10.1021/acschembio.3c00750. Epub 2024 Feb 10. ACS Chem Biol. 2024. PMID: 38340055 Free PMC article. - Genetic Changes in Mastocytes and Their Significance in Mast Cell Tumor Prognosis and Treatment.
Zmorzynski S, Kimicka-Szajwaj A, Szajwaj A, Czerwik-Marcinkowska J, Wojcierowski J. Zmorzynski S, et al. Genes (Basel). 2024 Jan 22;15(1):137. doi: 10.3390/genes15010137. Genes (Basel). 2024. PMID: 38275618 Free PMC article. Review. - Systemic mastocytosis with flushing and hypotension: A case report and literature review.
Chen AT, Ren XY, Chen W. Chen AT, et al. Exp Ther Med. 2021 Apr;21(4):404. doi: 10.3892/etm.2021.9835. Epub 2021 Feb 25. Exp Ther Med. 2021. PMID: 33692835 Free PMC article. - HO-1 reduces heat stress-induced apoptosis in bovine granulosa cells by suppressing oxidative stress.
Wang Y, Yang C, Elsheikh NAH, Li C, Yang F, Wang G, Li L. Wang Y, et al. Aging (Albany NY). 2019 Aug 12;11(15):5535-5547. doi: 10.18632/aging.102136. Epub 2019 Aug 12. Aging (Albany NY). 2019. PMID: 31404912 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous